[Page Banner Image]

The following is a review of diagnostic product developments worldwide

The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.

The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.

[HRule Image]

Product developments in February 2005

Abbott Diagnostics entered into a licensing agreement with The Cleveland Clinic for the development of an automated in vitro diagnostic test to detect myeloperoxidase (MPO), an enzyme found in white blood cells. Detecting elevated, circulating levels of MPO may be useful in determining a person's risk for adverse cardiac events such as a heart attack. Abbott also entered into an agreement with Nihon Kohden Corporation for the commercialization of automated hematology diagnostic instruments for use in hospital laboratories and physician offices. Two 5-part differential hematology instruments will be manufactured by Nihon Kohden and distributed by Abbott under the CELL-DYN Pearl brand name. Abbott obtains exclusive distribution rights for the two instruments in the United States and Canada and non-exclusive distribution rights for the instruments in other countries with the exception of China and Japan.

Biomerica, Inc. launched a test to measure levels of C-peptide in blood. Measurement of C-peptide levels allows clinicians to differentiate between Type I and Type II diabetes and may be to indicate the need for progression to insulin therapy in Type II diabetes.

BRAHMS Ag received FDA clearance to market the BRAHMS PCT-LIA to detect sepsis biomarker, procalcitonin. The PCT-LIA is a manual assay that uses a luminometer, Brahms also makes a semi-quantitative, rapid version of the assay, PCT Q, which is currently available for research purposes in the U.S., but will be submitted to the FDA for review this year.

Chembio Diagnostics, Inc., entered into a license and technology transfer agreement with Prionics AG. The agreement grants an exclusive license for Prionics to use Chembio's technology in the manufacturing of the Prionics Check PrioSTRIP, a rapid test for the detection of BSE.

ChromaVision Medical Systems changed the name of the corporation to Clarient, Inc. The company will be organized into three business units -- diagnostic services, which provides a full range of onsite and remote advanced cancer diagnostic testing; biopharmaceutical services, which provides technology and expertise to leading drug companies in pursuit of a new generation of targeted cancer therapies; and the company's legacy imaging equipment product line.

Ciphergen Diagnostics signed a research and license agreement with The University of Texas M. D. Anderson Cancer Center to utilize Ciphergen's ProteinChip System and associated bioinformatics suites to further their ongoing research in ovarian cancer. Ciphergen will analyze clinical samples provided by M. D. Anderson for ovarian cancer using its Deep Proteome and Pattern Track suite of proteomics tools. Ciphergen has exclusive rights to license discoveries made during the course of this collaboration.

Clinical Data, Inc. entered into a distribution agreement with Daiichi Pure Chemicals Co., Ltd. to distribute Daiichi's PSA test. Daiichi's assay technology allows PSA to be measured on Clinical Data's existing line of clinical chemistry analyzers and on most conventional clinical chemistry systems currently in use around the world.

GlucoLight Corporation is developing a non-invasive glucose sensor that can be used as a continuous monitor in a hospital setting and eventually as a portable monitor for use by diabetics. GlucoLight's uScatter (microscatter) technology is based on patented technologies in the area of Optical Coherence Tomography (OCT) and Low Coherence Interferometry (LCI). uScatter measures the scatter of light from cells to determine glucose levels in the interstitial fluid.

HemoGenix Inc. and Biotrin International Ltd. have developed the OxyFLOW Research Kit, a flow cytometry assay for detecting and quantifying oxidative DNA damage to lympho- hematopoietic cells as a result of stress, xenobiotics and the administration of drugs.

Inverness Medical Innovations, Inc. signed a definitive agreement to acquire Binax, Inc., manufacturer of rapid diagnostic products for infectious disease testing, primarily related to the respiratory system. Inverness has also acquired Ischemia Technologies, Inc. Ischemia developed the only FDA-cleared in vitro diagnostic test specifically targeted on cardiac ischemia, known as Ischemia Modified Albumin (IMA).

[HRule Image]

* Product developments - January 2005
* Product developments - December 2004
* Product developments - November 2004
* Product developments - October 2004
* Product developments - September 2004
* Product developments - May 2004
* Product developments - April 2004
* Product developments - March 2004
* Product developments - February 2004
* Product developments - January 2004
* Product developments - December 2003
* Product developments - November 2003
* Product developments - October 2003
* Product developments - September 2003
* Product developments - Summer 2003
* Product developments - May 2003
* Product developments - April 2003
* Product developments - March 2003
* Product developments - April 04003
* Product developments - January 2003
* Product developments - December 2002
* Product developments - November 2002
* Product developments - October 2002
* Product developments - September 2002
* Product developments - Summer 2002
* Product developments - June 2002
* Product developments - May 2002
* Product developments - April 2002
* Product developments - March 2002
* Product developments - April 04002
* Product developments - January 2002
* Product developments - December 2001
* Product developments - November 2001
* Product developments - October 2001
* Product developments - September 2001
* Product developments - Summer 2001
* Product developments - May 2001
* Product developments - April 2001
* Product developments - March 2001
* Product developments - April 04001
* Product developments - January 2001
* Product developments - December 2000
* Product developments - November 2000
* Product developments - October 2000
* Product developments - September 2000
* Product developments - July - August 2000
* Product developments - June 2000
* Product developments - May 2000
* Product developments - April 2000
* Product developments - March 2000
* Product developments - Febuary 2000
* Product developments - January 2000
* Product developments - December 1999
* Product developments - November 1999
* Product developments - October 1999
* Product developments - September 1999
* Product developments - August 1999
* Product developments - July 1999
* Product developments - June 1999
* Product developments - May 1999
* Product developments - April 1999
* Product developments - March 1999
* Product developments - Febuary 1999
* Product developments - January 1999
* Product developments - December 1998
* Product developments - November 1998
* Product developments - October 1998
* Product developments - September 1998
* Product developments - August 1998
* Product developments - July 1998
* Product developments - June 1998
* Product developments - May 1998
* Product developments - Avril 1998
* Product developments - March 1998
* Product developments - February 1998
* Product developments - January 1998
* Product developments - July 1997
* Product developments - June 1997
* Product developments - May 1997
* Product developments - April 1997
* Product developments - March 1997
* Product developments - February 1997
* Product developments - January 1997
* Product developments - December 1996
* Product developments - November 1996
* Product developments - October 1996
* Product developments - September 1996
* Product developments - August 1996
* Product developments - July 1996
* Product developments - June 1996

[HRule Image]

Home | Company Profile | Services | Research Reports Available
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links

[HRule Image]
Send mail to stratcom@pagebleu.com with questions or comments about this web site.

Concept and Design Blue Page Productions
Copyright 1996-2005 STRATCOM

Last modified: March 7, 2005